Basecamp Wealth Advisors’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Basecamp Wealth Advisors's BLTE Position: Q3 2026 in Review
Basecamp Wealth Advisors opened a new position in Belite Bio (BLTE) in Q3 2026: 76 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #854 among its holdings.
96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Basecamp Wealth Advisors held 76 shares of Belite Bio worth $12.9K as of Q3 2026.
- Belite Bio was a new Basecamp Wealth Advisors position in Q3 2026.
- Belite Bio made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #854 holding.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.